◼ Archived
Health
🔮 fades ✓
New weight loss pill that’s beating oral Ozempic
A new oral GLP-1 agonist pill outperforms Ozempic in clinical trials, reshaping obesity treatment
Fda Approval
5 independently checked trend briefs about this subject, newest first.
What this Fda Approval timeline shows
headlinez.news detected 5 source-qualified news clusters connected to Fda Approval between June 27, 2026 and July 12, 2026. They span 2 newsroom categories and average 7.0 independent sources per brief.
This hub includes only briefs supported by at least four sources and passed by the site's verification gate. Raw or weak detections may exist but are excluded here. Topic matching is based on the entities and themes recorded with each brief; open a card to inspect its source links, publication time, verification label and velocity history. Read the methodology and editorial policy for the full rules.
◼ Archived
Business
🔮 fades ✗
Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector
The FDA has granted approval for Sanofi’s Sarclisa, marking the first time a cancer medication has been cleared for delivery via an on-body injector.
◼ Archived
Business
🔮 holds ✓
FDA approves Vera Therapeutics kidney disease treatment
The FDA has granted accelerated approval to Vera Therapeutics for its new kidney disease drug, Trutakna, targeting primary IgA Nephropathy.
◼ Archived
Business
🔮 fades ✓
Why Psychedelics-Tied Compass Pathways Isn't Getting High
Compass Pathways' psychedelic depression drug shows promise but faces investor skepticism ahead of key filings
◼ Archived
Health
🔮 fades ✓
One Specific Blood Protein Can Identify Dementia Risk Decades Before Diagnosis
A single blood protein could redefine Alzheimer’s detection—decades before symptoms appear.